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 Implication for health policy/practice/research/medical education:
HBV genotype G is one of the least studied genotype. The identiﬁcation and determination of the particular epidemiologic and 
molecular characteristics of the circulating genotype G strain of HBV is important to enable better understanding of the progres-
sion of chronic hepatitis infections around the world.
Background: Genotype G is the least common of all the hepatitis B virus (HBV) genotypes. 
The existence of the genotype G strain of HBV was ﬁrst noted in 2000 and little informa-
tion is available on its global geographical distribution. Previous studies have demon-
strated the dominance of genotype D in patients with HBV infections in Turkey. 
Objectives: To report for the ﬁrst time in Turkey, the case of a 61 year old male patient who 
developed the HBV genotype G infection. 
Case report: According to HBV genotyping using phylogenetic analysis and an INNO-LiPA 
assay, the patient was infected with genotype G and G+A, respectively. 
Conclusions: The present clinical study suggests that the transmission of an HBV geno-
type other than genotype D, namely HBV genotype G, is possible in Turkey. Epidemio-
logical and clinical information on genotype G infection is currently limited, and this is 
most likely due to its low prevalence throughout the world. Therefore, it may be impor-
tant to determine the epidemiologic and molecular characteristics of the HBV genotype 
G as it relates to chronic hepatitis, to enable better understanding of its circulation and 
progression around the world.  Copyright  c 2012 Kowsar M. P. Co. All rights reserved. 
1. Background 
The existence of genotype G was ﬁrst noted in 2000 
and to date it has been localized in the United States, 
Canada, Brazil, Mexico, France, Germany, Vietnam, Thai-
land, and Japan (1-4). Genotype G is essentially identical 
to the other HBV genotypes, but it has some unique fea-
tures including a 36-bp insertion downstream of the core 
gene start codon. This results in a twelve amino acid (aa) 
insertion at the N-terminal end of the core protein, and 
two stop codons in the precore region that prevents the 
expression of HBeAg (1). Genotype G is the most uncom-
mon of all the HBV genotypes. This genotype is usually 
found as a coinfection with another HBV genotype (4). 
However, epidemiological and clinical information on 
the genotype G infection is limited, which is probably 
the result of its low worldwide occurrence (3). Previous 
studies have demonstrated the dominance of genotype 
D in patients chronically infected with HBV in Turkey (5, 
6). Nevertheless, transmission of genotypes (genotype 
A2/adw2) other than genotype D HBV is also possible in 
Turkey (7). In this study, we report on the case of a male 
patient who developed the HBV genotype G infection, 
and reveal its coinfection with other HBV genotypes for 
the ﬁrst time in Turkey.119
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2. Case Report
The study patient was a 61 year old male diabetic who 
had been treated with hemodialysis three times per 
week for 4 years, due to idiopathic end stage renal dis-
ease. Twelve years earlier, the patient had been diag-
nosed with brucellosis. At that time, he was hospital-
ized and hepatitis B surface antigen (HBsAg) positivity 
was detected for the ﬁrst time. No other members of his 
family were shown to have a hepatitis B infection on 
examination. The patient had never used intravenous 
drugs in the past and had no history of blood transfu-
sion, nor had he ever traveled abroad. The patient did, 
however, have a history of multiple sexual partners. The 
laboratory analyses yielded; transaminase levels, ALT:41 
U/L, AST:25 U/L; bilirubin levels, BU:0.1mg/dl, BC:0.3 mg/
dl; HBsAg, positive (S/Co:3894); anti HBs antibody, nega-
tive; anti-HBcAg total antibody (anti-HBcIgG), positive; 
anti-HBcAg IgM antibody (anti-HBcIgM), negative; HBeAg 
antigen (HBeAg), negative; anti-HBe antibody (anti-HBe), 
positive; HBV DNA load, 5.94E+05 IU/ml; anti-HAV IgG, 
positive. Our case was characterized by seronegativity 
for HDV, HCV and HIV (he was also HIV-PCR negative) and 
with autoantibody negativity (anti-nuclear, anti-mito-
chondrial, anti-double stranded DNA and anti-smooth 
muscle antibodies). The patient did not give his consent 
for a liver biopsy procedure; therefore assessment of 
liver damage was not possible. The patient was evalu-
ated as having “HBeAg - negative chronic hepatitis B,” 
according to the European Association for the Study of 
the Liver (EASL)clinical practice guidelines, and he was 
treatment naive. Serological markers for HBV were tested 
using the commercially available microparticle enzyme 
immunoassay kit (AxSYM, Abbott Laboratories, IL, USA). 
HBV DNA was isolated from the serum sample on the 
bio-robot workstation, using magnetic-particle technol-
ogy (QIAsymphony SP, QIAGEN GmbH, Hilden, Germany). 
HBV DNA was detected and quantiﬁed by a commercial 
PCR assay (artus HBV QS-RGQ test, QIAGEN GmbH, Hilden, 
Germany) on the real-time platform (Rotor-Gene Q, QIA-
GEN GmbH, Hilden, Germany). A pair of primers was de-
signed (forward: 5’-TCGTG GTGGACTTCTCTCAATT-3’ and 
reverse: 5’-CGTTGACAGACTTTCCAATCAAT-3’) for ampli-
ﬁcation of the HBV pol gene region (pol gene sequence 
used routinely for HBV genotyping and genotypic resis-
tance analysis to nucleos(t)ide analogues in our clinical 
laboratory). The PCR conditions were applied as previ-
ously described (7).
2.1. HBV Genotyping by DNA Sequencing
HBV genotype was determined by phylogenetic 
analysis. The nucleotide sequence was compared 
to those from the international DNA data bank 
(GenBank+EMBL+DDBJ+PDB). Phylogenetic comparison 
was performed by UPGMA analysis using the CLC Se-
quence Viewer 6.0.2 (CLC bio A/S, Aarhus, Denmark) soft-
ware. However, the HBV genotype was also determined 
with the Basic Local Alignment Search Tool (BLASTN 
program 2.2.25, blast.ncbi.nlm.nih.gov) and by various 
genotyping tools; (I), The National Center for Biotechnol-
ogy Information (NCBI, U.S National Library of Medicine, 
Bethesda - USA, www.ncbi.nih.gov), (II), The Genafor/
Arevir - Geno2pheno Drug Resistance Tool (Center of Ad-
vanced European Studies and Research, Bonn - Germany, 
www.coreceptor.bioinf.mpi-inf.mpg.de), (III), and Stan-
ford University HBV Drug Resistance Database (HBVseq: 
Sequence Analysis, hivdb.stanford.edu/HBV/HBVseq) 
2.2. HBV Genotyping by Inno-Lipa
Extracted HBV DNA was ampliﬁed with biotinylated 
primers using AmpliTaq Gold DNA polymerase (Applied 
Biosystems, Inc., California, USA) and PCR buﬀer provid-
ed in the INNO-LiPA HBV genotyping kit (Innogenetics, 
Gent, Belgium) according to the manufacturer’s instruc-
Genotyping Tool Genotype (Maximum Identity), % Molecular Feature
BLASTN G, 94.0 a Stop codon + frame shift b
NCBI G, 98.0 c ND d
HBV seq G, 94.5   ND d
Geno2pheno G, 96.6 Insertion
In the surface protein, [ins.]148aT
In the RT domain, [ins.]123aT
Mutation e 
İn the surface protein, sM133T
İn the RT domain, rtN238T
Table 1. Genotyping Match and Molecular Features of HBV Isolates on the Diﬀerent Genotyping  Tools
a Maximum identity to strain with GenBank accession no: AF405706.1 
b The protein translation contains stop codons within the coding region and BLASTx similarity search results indicates these are frameshift. Analysis 
also on the Vector NTI v5.1 program has determined insertions (aT) on the base position numbers 148. and 123. in large S protein (a ORF, 492 bp) and RT 
domain (a ORF, 651 bp), respectively. 
c Maximum score was 284 to strain with GenBank accession no: AF405706.1 
d Not determined
esM133T mutation is a typical HBsAg escape mutation (17) . rtN238T is a compensatory mutation occure in adefovir therapy (18).120
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tions. The Lipa procedure was completed using the Auto-
LiPA instrument (Innogenetics, Gent, Belgium). Phyloge-
netic analysis of the pol gene sequence showed that the 
isolate 181 clustered on a genotype G branch (Figure 1). 
The isolate 181 was also classiﬁed as genotype G according 
to subtyping tools (Table 1). The genotyping match and 
molecular features of the HBV isolate as indicated by the 
diﬀerent genotyping tools are illustrated (Table 1).  The 
biotinylated PCR product showed A + G mixed genotype 
infections with single reactive lines for genotype A and 
G on the INNO-LiPAHBV genotyping assay, respectively. 
After the pol gene sequence of the HBV isolate 181 was 
submitted, it was assigned a GenBank accession number: 
JN010438.
3. Discussion
This study reports the ﬁrst recorded case of a Turkish 
patient being infected with the HBV genotype G. In 1990, 
an insertion of 36 nucleotides in the core region of the 
HBV characteristic of genotype G, was ﬁrst identiﬁed in 
men who have had sex with other men (8). Since then, 
this genotype has been identiﬁed as HBV genotype G in 13 
chronic carriers from the Georgia area of the USA, and in 
France (1). Genotype G HBV infection has frequently been 
reported with other HBV genotypes, such as genotype A 
(usually) or H (rare), but its clinical signiﬁcance is not yet 
very clear due to limited reports (4, 9, 10). Meanwhile, 
HBV genotype G coinfection with HIV has been described 
and reported from Brazil (2 out of 2 patients had HIV in-
fection), Mexico (5 out of 5 patients had HIV infection), 
Germany (1 patient had HIV infection), France (3 out of 4 
patients had HIV infection), Japan (2 out of 2 patients had 
HIV infection), and in the Cincinnati area of the USA (8 
out of 33 patients had HIV infection) (2, 3, 11-13). The pres-
ent case study is an adult male, and his history of sexual 
relations with multiple partners may be identiﬁed as a 
risk factor for the transmission of HBV genotype G. The 
ﬁrst HBV genotype G isolate in Mexico was obtained from 
a female sex worker (2), and since then it has been iso-
lated from 4 men who had had sex with other men (10). 
Various HBV genotype G strains were reported from the 
San Francisco area of the USA (9, 14). These strains could 
most probably have been acquired via sexual transmis-
sion. In a recently published report, detection with a spe-
ciﬁc method for HBV genotype G, on HBV-HIV coinfected 
patients, a 25% HBV genotype G prevalence was found, 
while it was below 1% in HBV monoinfections (15). Never-
theless, there is insuﬃcient information related to the 
sexual transmission of HBV genotype G and its associa-
tion with HIV. The data previously obtained from Turkish 
patients indicated that the sequenced HBV did not show 
any genetic diversity. It has recently been reported that 
genotype D HBV is still predominant among Turkish pa-
tients who are chronically infected with HBV (5, 6). Those 
studies related HBV genotyping based on phylogenetic 
trees or subtyping tools and used population based se-
quencing. Meanwhile, the present case study showed 
A+G mixed genotype infection on the INNO-LiPA assay. 
This data demonstrates that sequence analysis is not the 
method of choice for determining the presence of mixed 
genotype infections. INNO-LiPA genotyping is based on 
reverse hybridization and is able to detect minor HBV 
subpopulations.  Osiowy et al. reported that INNO-LiPA 
HBV genotyping assay was sensitive in detecting A+B, 
A+C and A+G mixed genotype infections compared with 
direct sequencing (16). However, genotype G infection 
usually occurred as a coinfection with other HBV geno-
types, therefore testing for the detection of genotype G 
should be included in the INNO-LiPA HBV genotyping as-
say. In summary, the genotype G HBV had never been re-
ported before in Turkey, but our study suggests that the 
transmission of genotypes other than genotype D HBV is 
possible in Turkey. In the genotyping of HBV using phylo-
genetic analysis, various subtyping tools and the INNO-
LiPA  HBV genotyping assay may be more useful used in 
conjunction, for the identiﬁcation of molecular features 
and to reveal coinfection with HBV genotype G, respec-
tively. At the same time, circulation of the HBV genotype 
G strain is global, and genotype G is one of the least stud-
ied genotypes of HBV. Therefore in conclusion, it can be 
said that the identiﬁcation and determination of the 
particular epidemiologic and molecular characteristics 
of the circulating genotype G strain of HBV is important 
to enable better understanding of the progression of 
chronic hepatitis infections around the world.
Neighbor-Joining Analysis Was Carried Out With Other Sequences From all HBV Genotypes From GenBank Using CLC Sequence Viewer 6.5.1 (CLC bio A/S, 
Aarhus, Denmark) Software. Bootstrap Support Value (1000 Replicates) are Shown at the Respective Branches. Strain Called 181 is Obtained From a Hemo-
dialysis Patient (GenBank Accession Number.JN010438)
Figure. 1. Phylogenetic Tree of Hepatitis B Virus Pol Gene (768 bp) Region121
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